New Results
Inhibition of the TPL2-MKK1/2-ERK1/2 pathway has cytostatic effect on B-Cell Lymphoma
Mariana Asslan, Guy Martel, View ORCID ProfileSimon Rousseau
doi: https://doi.org/10.1101/2022.06.13.495940
Mariana Asslan
1The Meakins-Christie Laboratories at the Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada
Guy Martel
1The Meakins-Christie Laboratories at the Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada
Simon Rousseau
1The Meakins-Christie Laboratories at the Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada
2Department of Medicine, McGill University, Montreal, Quebec, Canada
Article usage
Posted June 16, 2022.
Inhibition of the TPL2-MKK1/2-ERK1/2 pathway has cytostatic effect on B-Cell Lymphoma
Mariana Asslan, Guy Martel, Simon Rousseau
bioRxiv 2022.06.13.495940; doi: https://doi.org/10.1101/2022.06.13.495940
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8749)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12086)
- Cell Biology (17403)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16795)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11582)
- Neuroscience (60936)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10423)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)